Davida Kruger, MSN, and John McGinnity, PA-C, present this CME webinar “A New Paradigm in Cardiovascular Risk Reduction in Type 2 Diabetes”. Learn the latest on the hottest topic in T2DM Management: CV RISK!
This course features 20 sessions designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Topics include: Cardiology, Diabetes, Endocrinology, Gastroenterology, Hepatology, Infectious Disease, Nephrology, Psychiatry, Pulmonology, Rheumatology, and Women’s Health.
Hypoglycemia is common in type 1 diabetes and also common in type 2 diabetes. Hypoglycemia unawareness can occur after repeated episodes of hypoglycemia and is of great concern due to the risk of severe hypoglycemia.
This activity will examine practical evidence-based techniques for selecting and implementing weight loss options to improve health outcomes in overweight patients. Focus will be on engaging patients to promote adherence in weight loss programs that meet their individual needs, including those that use weight loss medications.
This CME article will present the clinical realities of obesity encouraging an open provider/patient relationship that enhances care, allowing for discussions on goals, adherence, barriers, and expectations.
This activity will provide the participant with the latest up-to-date information for thyroid disease and review of treatment for both subclinical and overt disease. Discussion will include management of therapeutic options as well as counseling, screening, and monitoring the pregnant thyroid patient.
This educational activity will discuss appropriate screening and assessment for glycemia and associated comorbidities and review safety, efficacy, mechanisms of action, and place for non-insulin therapies within the treatment algorithm.
This activity was developed from the live Best Practices in Primary Care™ program held in Chicago, Illinois on June 21, 2014. The expert faculty will discuss the strategies pertaining to appropriate initiation and intensification of insulin therapy.
Hypogonadism is an underdiagnosed syndrome with links to age, obesity, type 2 diabetes mellitus (T2DM), and metabolic syndromes. This activity will help clinicians with appropriate screening, diagnosis, and available testosterone supplemental therapies.